CRNX

Crinetics Pharmaceuticals Inc.

Price

$84.69

return (12m)

187.77%

p/e

-17.89

p/bv

7.53

DIVIDEND YIELD

0.00%

CRNX price

Crinetics Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.94%

3 months

128.34%

1 year

187.77%

2 years

60.03%

5 years

305.80%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CRNX

Valuation

P/E

-17.89

Sector -4.38

Industry -4.38

P/BV

7.53

Sector 2.02

Industry 2.02

P/Revenue (PSR)

212.89

Sector -4.40

Industry -4.40

EV/EBITDA

-59.12

Sector -263.09

Industry -263.09

EV/EBIT

-58.64

Sector -702.90

Industry -702.90

P/EBITDA

-16.47

Sector -4.39

Industry -4.39

P/EBIT

-16.34

Sector -4.73

Industry -4.73

P/Total Assets

6.79

Sector 1.49

Industry 1.49

P/Net Current Assets

8.05

Sector -11.70

Industry -11.70

P/Working Capital

7.71

Sector -3.19

Industry -3.19

EPS

-4.73

Sector -2.14

Industry -2.14

BVPS

11.24

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

99.15%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-523.05%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-527.31%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.02

Sector 0.03

Industry 0.03

Profitability

ROE

-42.08%

Sector -65.14%

Industry -65.14%

ROA

-37.95%

Sector -65.53%

Industry -65.53%

ROIC

-465.78%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

15.57

Sector 2.90

Industry 2.90

Net Debt / EBITDA

9.18

Sector -6.07

Industry -6.07

Net Debt / EBIT

9.10

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.01

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.90

Sector 0.41

Industry 0.41

Liabilities/Assets

0.10

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

108.10%

Sector -

Industry -

5Y Earnings CAGR

36.05%

Sector -

Industry -

Fundamentals CRNX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CRNX Crinetics Pharmaceuticals Inc.	$84.69	184.77%	0.00%	-17.89	7.53	-42.08%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CRNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2018

Time since IPO - 8 years

93

Employees

Crinetics Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $8.97 billion, with shareholders equity totaling $1.19 billion.

The company employs approximately 93 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Crinetics Pharmaceuticals Inc. reported $42.15 million in revenue, generating net income of $-501.60 million.

Key financial metrics include a P/E ratio of -17.89, a price-to-book (P/B) ratio of 7.53, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRNX.

Market cap

$8.97 billion

Net worth

$1.19 billion

$1,191,960,000.00

Assets

$1.32 billion

$1,321,880,000.00

Total Shares Outstanding

106.00 million

106,000,000

Average Daily Trading Volume

$4.49 million

$4,487,761.68

Sector

Health Care

Industry

Biotechnology

CRNX

CRNX revenue and profits

Financial Results CRNX

DRAG THE FRAME TO SEE MORE DATA

CRNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Crinetics Pharmaceuticals (CRNX) today?

A cotação de Crinetics Pharmaceuticals (CRNX) hoje está em US$ 84.69, com uma variação de 187.77% em relação ao último ano. A cotação de Crinetics Pharmaceuticals (CRNX) iniciou o ano negociando na casa dos US$ 46.55 e hoje está em US$ 84.69. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Crinetics Pharmaceuticals (CRNX) e dados de ações do Ibovespa e mercados internacionais.

Quando Crinetics Pharmaceuticals (CRNX) paga dividendos?

Crinetics Pharmaceuticals (CRNX) não distribuiu dividendos no último ano.

Is Crinetics Pharmaceuticals (CRNX) a good investment?

Atualmente, Crinetics Pharmaceuticals (CRNX) está cotada a US$ 84.69, com um P/L de -17.89, representando um desvio de -1,207% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 187.77 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 187.77%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Crinetics Pharmaceuticals (CRNX) stock?

Investir em ações de Crinetics Pharmaceuticals (CRNX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Crinetics Pharmaceuticals (CRNX) yield today?

A rentabilidade de Crinetics Pharmaceuticals (CRNX) foi de 0.94% no último mês, 187.77% no último ano e 305.80% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Crinetics Pharmaceuticals (CRNX) hoje, o investimento total seria de US$ 8,469.00, com base na cotação atual de US$ 84.69.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 24,371.24
Em 5 anos: US$ 34,367.20
Em 10 anos: US$ 8,469.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CRNX

Crinetics Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CRNX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CRNX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Inc.

United States

18 years

2018

93

PROFIT X PRICE CRNX

Financial Results CRNX

CRNX cash flow

Asset, Revenue and Profit Growth - CRNX

CRNX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions